tavneos

The FDA Move to Withdraw Approval of the Vasculitis Drug Tavneos Exposes Deep Flaws in Clinical Trial Integrity

The United States Food and Drug Administration (FDA) is currently engaged in a high-stakes regulatory battle to withdraw the marketing…